Cargando…
Case Report: Limbic encephalitis following treatment with durvalumab for small-cell lung cancer
BACKGROUND: Durvalumab is an immune checkpoint Inhibitor (ICIs) that is used in the treatment of malignant tumors, such as lung cancer and melanoma. ICIs are associated with immune-related adverse events including autoimmune encephalitis, although both paraneoplastic phenomena and ICI treatment may...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613972/ https://www.ncbi.nlm.nih.gov/pubmed/37908347 http://dx.doi.org/10.3389/fimmu.2023.1278761 |